Nervgen remyelination drug phase 1
Re: Nervgen remyelination drug phase 1
https://finance.yahoo.com/news/nervgen- ... 01%20Trial
"...Phase 1 program supports plan to start clinical trials in H2 2022 for NervGen's NVG-291 in spinal cord injury, multiple sclerosis and Alzheimer's disease indications
Screening of healthy volunteers has already started for the trial's multiple ascending dose (MAD) portion
In preclinical studies, NVG-291 has been shown to promote repair of nervous system damage...?
"...Phase 1 program supports plan to start clinical trials in H2 2022 for NervGen's NVG-291 in spinal cord injury, multiple sclerosis and Alzheimer's disease indications
Screening of healthy volunteers has already started for the trial's multiple ascending dose (MAD) portion
In preclinical studies, NVG-291 has been shown to promote repair of nervous system damage...?